A new mobile app developed by the Rare Diseases Clinical Research Network (RDCRN) makes it easier than ever for CMT patients to sign up for and navigate the network’s patient registry, which will play a key role in identifying patients ...
The MDA and the CMTA have formed a partnership aimed at advancing CMT research, therapy development and clinical care, while also increasing awareness and understanding of CMT by improving education for patients, medical professionals and the public.
The MDA and the CMTA today announced a research grant totaling $119,999 to Kleopas Kleopa, MD, for a study on the effectiveness of a gene therapy approach in the second most common form of Charcot-Marie-Tooth disease (CMT).
Invitae Corporation, a genetic information company, today announced it has expanded its neurology test offering, adding 11 new panels for heritable diseases and updating 17 existing neurology panels based on new discoveries in genetics research.